Postdoctoral Research Assistant in Epigenetics and Cancer

Department: Wolfson Institute of Population Health
Salary: £35,775 – £42,021 (Grade 4)
Reference: QMUL30458
Location: Charterhouse Square
Date posted: 25 October 2022
Closing date: 22 November 2022

Further details and apply

Overview

About the Role

The Molecular and Epidemiology Lab (MEL) is recruiting a highly-qualified postdoc scholar for research projects related to epigenetic-based cancer diagnostics incorporating novel microfluidic devices. The individual will be responsible for applying methylation assay and next-generation sequencing methods towards identifying epigenetic biomarkers of early-stage HPV-related cancers and developing targeted assays amenable to implementation in custom point-of-care devices.

The successful applicant will join a world-renowned, highly interdisciplinary team of scientists and medical researchers with the goal of developing low-cost solutions for the non-invasive detection of multiple cancer types.

About You

You should be ambitious and keen to progress in an academic career. You should have expertise in assays development and molecular biology techniques, and an excellent understanding of cancer biology. You will be experienced in the field of epigenetics, and highly proficient in data analysis. You will be an excellent communicator, with a proven ability to write papers and scientific reports. Applicants must hold a PhD in epigenetics, molecular biology or a related field.

About the School/Department/Institute/Project

The Wolfson Institute of Population Health (WIPH) harnesses expertise across a wide range of population-based research and education activities and aims to be an internationally recognised centre-of-excellence in population health and preventive medicine.

As one of the five centres within the WIPH, the Centre for Prevention, Detection and Diagnosis is at the forefront of research internationally into the prevention, detection and control of cancer.  We have particularly active programmes in research studying breast, cervical, colorectal, lung, pancreatic and prostate cancer prevention, cancer screening, early diagnosis, and statistical methods for clinical trials and epidemiology. An integral part of the Centre, the MEL is specialised in the detection of cervical cancer and has strong expertise in the field of cancer screening.

About Queen Mary

At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.

Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.

We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.

Benefits

We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies and flexible working arrangements.

The post is based at the Charterhouse Square Campus in London. It is fixed-term appointment to 31 October 2024. The starting salary will be Grade 4, in the range of £35,775 – £42,021 per annum, inclusive of London Allowance.

Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability.

Informal enquiries should be addressed to Dr Belinda Nedjai at [email protected].

To apply for the role, please click the ‘apply’ button above.

The closing date for applications is 22 November 2022.

Interviews will be held shortly thereafter.

Valuing Diversity & Committed to Equality

Further details and apply